Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.

NCT01983267 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

1- Cancer Patients During Chemotherapy Treatment
2- Use of Cannabis Comparing to Control Without Cannabis Use

Interventions

DRUG: cannabis

Sponsor

Rambam Health Care Campus